Hemostatic Management in Extracorporeal Membrane Oxygenation.

IF 1 Q4 CRITICAL CARE MEDICINE

Critical Care Nursing Quarterly Pub Date : 2022-04-01 DOI:10.1097/CNQ.0000000000000396

Hannah M Brokmeier, Erin D Wieruszewski, Scott D Nei, Theodore O Loftsgard, Patrick M Wieruszewski

引用次数: 5

Abstract

The use of extracorporeal membrane oxygenation (ECMO) for acute cardiac and/or respiratory failure has grown exponentially in the past several decades. Systemic anticoagulation is a fundamental element of caring for ECMO patients. Hemostatic management during ECMO walks a fine line to balance the risk of safe and effective anticoagulant delivery to mitigate thromboembolic complications and minimizing hemorrhagic sequelae. This review discusses the pharmacology, monitoring parameters, and special considerations for anticoagulation in patients requiring ECMO.

查看原文本刊更多论文

体外膜氧合中的止血管理。

在过去的几十年里，体外膜氧合(ECMO)治疗急性心脏和/或呼吸衰竭的应用呈指数增长。全身抗凝是ECMO患者护理的基本要素。ECMO期间的止血管理要平衡安全有效的抗凝药物输送风险，以减轻血栓栓塞并发症并最大限度地减少出血后遗症。这篇综述讨论了需要ECMO的患者抗凝治疗的药理学、监测参数和特殊注意事项。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Critical Care Nursing Quarterly CRITICAL CARE MEDICINE-

CiteScore

2.60

自引率

0.00%

发文量

期刊介绍： Critical Care Nursing Quarterly (CCNQ) is a peer-reviewed journal that provides current practice-oriented information for the continuing education and improved clinical practice of critical care professionals, including nurses, physicians, and allied health care professionals.